Title | Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. |
Publication Type | Journal Article |
Year of Publication | 2013 |
Authors | Kamphorst, JJ, Cross, JR, Fan, J, de Stanchina, E, Mathew, R, White, EP, Thompson, CB, Rabinowitz, JD |
Journal | Proc Natl Acad Sci U S A |
Volume | 110 |
Issue | 22 |
Pagination | 8882-7 |
Date Published | 2013 May 28 |
Keywords | Animals, Autophagy, bcl-2 Homologous Antagonist-Killer Protein, bcl-2-Associated X Protein, Carbon Isotopes, Cell Hypoxia, Cell Line, Tumor, Cell Proliferation, Fatty Acids, Glucose, Glutamine, Humans, Lipogenesis, Mice, Mice, Knockout, Neoplasms, Oxygen Consumption, Phospholipids, Pinocytosis, ras Proteins, Stearoyl-CoA Desaturase |
Abstract | Cancer cell growth requires fatty acids to replicate cellular membranes. The kinase Akt is known to up-regulate fatty acid synthesis and desaturation, which is carried out by the oxygen-consuming enzyme stearoyl-CoA desaturase (SCD)1. We used (13)C tracers and lipidomics to probe fatty acid metabolism, including desaturation, as a function of oncogene expression and oxygen availability. During hypoxia, flux from glucose to acetyl-CoA decreases, and the fractional contribution of glutamine to fatty acid synthesis increases. In addition, we find that hypoxic cells bypass de novo lipogenesis, and thus, both the need for acetyl-CoA and the oxygen-dependent SCD1-reaction, by scavenging serum fatty acids. The preferred substrates for scavenging are phospholipids with one fatty acid tail (lysophospholipids). Hypoxic reprogramming of de novo lipogenesis can be reproduced in normoxic cells by Ras activation. This renders Ras-driven cells, both in culture and in allografts, resistant to SCD1 inhibition. Thus, a mechanism by which oncogenic Ras confers metabolic robustness is through lipid scavenging. |
Alternate Journal | Proc. Natl. Acad. Sci. U.S.A. |